Having data about our bodies tracked is so much a part of our daily lives that we sometimes forget it can be used against us.
When the Supreme Court overturned Roe v. Wade in 2022, a deluge of articles warned people to delete their menstrual tracking apps. While these technologies can be useful for those seeking (or avoiding) pregnancy, these apps have come under fire in the past for selling intimate data to social media sites. With the changing legal landscape, privacy experts pointed out that this data could be used to criminalize people seeking abortions. Proponents of forced birth also recognize this potential, and are working to ensure that menstrual data remains open to search warrants. Turning this data into a site of political contestation raises questions of collective response beyond the limits of bodily autonomy.
It’s become normalized for data about our bodies and actions to be collected, quantified, and sold on the market. Facial recognition and body scans have become necessary to travel. Employer health insurance can require divulging health information from blood pressure to sexual...
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
Aggregated News
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Aggregated News
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.